Functional Blood Analysis for Clinical Application in Sepsis
We want to prepare the commercialisation of a novel clinical diagnostic test for the status of the immune system – the mechanical haemogram – with the purpose of improving the therapy management of severe infections, in particular...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PTA2011-5619-T
DISEÑO Y EVALUACIÓN DE NUEVAS TECNOLOGIAS PARA EL DIAGNÓSTIC...
57K€
Cerrado
FJC2020-042966-I
Early diagnosis of infectious diseases based on detecting ho...
53K€
Cerrado
CPP2021-008394
El primer dispositivo-Lector point of careque permite anal...
960K€
Cerrado
PTQ2020-011354
Desarrollo y validación de un test rápido de proteínas e inm...
70K€
Cerrado
PTQ-17-09111
Desarrollo de un inmunoensayo ultrasensible y multiplexado p...
57K€
Cerrado
CPP2021-008464
Desarrollo de una nueva herramienta inteligente y predictiva...
769K€
Cerrado
Información proyecto BASIC
Duración del proyecto: 18 meses
Fecha Inicio: 2018-01-12
Fecha Fin: 2019-07-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
We want to prepare the commercialisation of a novel clinical diagnostic test for the status of the immune system – the mechanical haemogram – with the purpose of improving the therapy management of severe infections, in particular in case of sepsis. Sepsis is ranked the third most common cause of death worldwide, and represents one of the most challenging problems even in modern health care systems. Our test is based on the analysis of single cell mechanical properties of white blood cells found in peripheral blood. Those properties serve as functional biomarker for the activation status of the immune system. With this test, we aim to provide an early detection of sepsis and direct monitoring of treatment effects for an efficient therapy management. The goal of the proposed project is to create and evaluate a business case for the successful implementation of this in vitro diagnostic test for clinical application in sepsis management.